Literature DB >> 23642971

Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: an observational study.

Annu Heinonen1, Anna-Maija Tapper, Arto Leminen, Harri Sintonen, Risto P Roine.   

Abstract

OBJECTIVE: To evaluate health-related quality of Life (HRQoL) in patients with abnormal cervical cytology referred for colposcopy. STUDY
DESIGN: An observational study with prospective and retrospective cohorts. In the prospective arm 240 women referred for colposcopy filled in the 15D HRQoL and the State Anxiety Inventory (STAI) questionnaires and were followed up for 12 months. In the retrospective arm 208 patients who had been treated for cervical dysplasia eight years earlier filled in the 15D HRQoL questionnaire. Results were compared with the age- and sex-standardized general population.
RESULTS: In the prospective part of the study, the mean 15D score of the patients did not differ from that of the general population. On the dimensions of sleeping, distress and sexual activity, however, the patients scored lower than the general population (p<0.001). Patients with higher levels of anxiety at baseline, according to the STAI questionnaire, had lower HRQoL during the whole 12-month observation period (p<0.001). The overall HRQoL score of the patients treated for cervical dysplasia eight years earlier did not differ from that of the general population.
CONCLUSIONS: Abnormal cytology and referral for colposcopy were associated with anxiety and slightly impaired psychosocial components of HRQoL but did not reduce the overall HRQoL. High anxiety levels at baseline were associated with impaired HRQoL. Previous treatment for cervical dysplasia was not associated with impaired overall HRQoL.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Abnormal cervical cytology; Cervical dysplasia; Condyloma; HPV; HRQoL

Mesh:

Year:  2013        PMID: 23642971     DOI: 10.1016/j.ejogrb.2013.03.033

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

Review 1.  Health-related quality of life as measured by the EQ-5D in the prevention, screening and management of cervical disease: A systematic review.

Authors:  A Ó Céilleachair; J F O'Mahony; M O'Connor; J O'Leary; C Normand; C Martin; L Sharp
Journal:  Qual Life Res       Date:  2017-06-26       Impact factor: 4.147

2.  Health-related quality of life in women after colposcopy: results from a longitudinal patient survey.

Authors:  M O'Connor; A Ó Céilleachair; K O'Brien; J O'Leary; C Martin; T D'Arcy; G Flannelly; J McRae; W Prendiville; C Ruttle; C White; L Pilkington; L Sharp
Journal:  Qual Life Res       Date:  2021-04-01       Impact factor: 4.147

Review 3.  Does treatment for cervical and vulvar dysplasia impact women's sexual health?

Authors:  Blanca R Cendejas; Karen K Smith-McCune; Michelle J Khan
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

4.  The Swedish translation and cross-cultural adaptation of the Functional Assessment of Chronic Illness Therapy - Cervical Dysplasia (FACIT-CD): linguistic validity and reliability of the Swedish version.

Authors:  Marie Rask; Marie Oscarsson; Neil Ludwig; Katarina Swahnberg
Journal:  BMC Womens Health       Date:  2017-04-04       Impact factor: 2.809

5.  Psychological distress in cervical cancer screening: results from a German online survey.

Authors:  M Jentschke; R Lehmann; N Drews; A Hansel; M Schmitz; P Hillemanns
Journal:  Arch Gynecol Obstet       Date:  2020-06-27       Impact factor: 2.344

6.  Validity and reliability of State-Trait Anxiety Inventory in Danish women aged 45 years and older with abnormal cervical screening results.

Authors:  L W Gustafson; P Gabel; A Hammer; H H Lauridsen; L K Petersen; B Andersen; P Bor; M B Larsen
Journal:  BMC Med Res Methodol       Date:  2020-04-23       Impact factor: 4.615

7.  Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.

Authors:  Steffie K Naber; Suzette M Matthijsse; Kirsten Rozemeijer; Corine Penning; Inge M C M de Kok; Marjolein van Ballegooijen
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.